Answer to Controversy: miR-10a Replacement Approaches Do Not Offer Protection against Chemotherapy-Induced Gonadotoxicity in Mouse Model
It is well known that chemotherapeutic agents may lead to premature ovarian failure and infertility. Therefore, fertility preservation is highly recommended for female cancer survivors. Despite the currently available techniques, new, non-invasive methods need to be developed to protect the ovarian...
Main Authors: | Chrysanthi Alexandri, Christina-Anna Stratopoulou, Isabelle Demeestere |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/19/4958 |
Similar Items
-
Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation
by: Gilad Karavani, et al.
Published: (2021-05-01) -
Adjuvant gonadotropin releasing hormone analog in gonadotoxic chemotherapy for preservation of fertility
by: K. V. S. Hari Kumar, et al.
Published: (2013-01-01) -
Oncofertility: Pharmacological Protection and Immature Testicular Tissue (ITT)-Based Strategies for Prepubertal and Adolescent Male Cancer Patients
by: Elissavet Ntemou, et al.
Published: (2019-10-01) -
Chemotherapy-induced Gonadotoxicity
by: Peng-Hui Wang, et al.
Published: (2010-03-01) -
Tissue Engineering to Improve Immature Testicular Tissue and Cell Transplantation Outcomes: One Step Closer to Fertility Restoration for Prepubertal Boys Exposed to Gonadotoxic Treatments
by: Federico Del Vento, et al.
Published: (2018-01-01)